Dr Sarah Best (left) and Dr Kate Sutherland (IMAGE)

Walter and Eliza Hall Institute

Dr Sarah Best (left) and Dr Kate Sutherland

Caption

Dr Sarah Best (left) and Dr Kate Sutherland from the Walter and Eliza Hall Institute, Melbourne, led a team that revealed a unique molecular signature in the blood that could be used to detect aggressive lung cancers with a simple blood test and identify patients who will respond to immunotherapies.

Credit

Walter and Eliza Hall Institute

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.